COVID-19

Developments
The COVID-19 pandemic has challenged our families, our businesses and our communities. Fast-moving and uncertain situations related to COVID-19 are affecting all of us, and in this time of uncertainty we are working to collect and share as much information as possible related to the workers’ comp industry.
All Developments
Clinical Developments
Industry Developments
Regulatory Developments
An exploration of job loss due to the COVID-19 pandemic.
READ MORE
The anti-malaria drug is no longer deemed effective.
READ MORE
Certain occupations require different levels of protection.
READ MORE
Could Arkansas and Louisiana start a trend?
READ MORE
WCIRB analyzes historic data on economic cycles.
READ MORE
A report on claim data up to May 31st.
READ MORE
Positive trials bode well for this antiviral.
READ MORE
COVID-19 claim data was gathered in a survey to understand impacts to comp.
READ MORE
This announcement impacts 31 antibody tests.
READ MORE
Saliva samples collected at-home must be sent to the designated lab.
READ MORE
A collection of facts and figures surrounding the COVID-19 pandemic
READ MORE
More states relax telehealth rules. New update: Utah & Illinois Join, Connecticut Provides Clarity
READ MORE
Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.
READ MORE
April 30, 2020
The FDA and JAMA think blood from those who recovered from COVID-19 could benefit those still ill.
READ MORE
Lists of compiled information on telehealth, public notices, and more.
READ MORE
April 21, 2020
Testing for COVID-19 antibodies is not a conclusive test for infection.
READ MORE
April 21, 2020
This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
READ MORE
April 20, 2020
$25 million each for essential worker and essential business support funds.
READ MORE
Information on layoffs, shutdowns, access to care, and more.
READ MORE
April 14, 2020
The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
READ MORE
Providers receive more time in light of system disruptions due to COVID-19
READ MORE
Emergency rules expiring April 13th expanded indefinitely.
READ MORE
April 10, 2020
A message from Healthesystems leadership.
READ MORE
Healthesystems’ AVP of Advocacy & Compliance discusses the massive state and federal responses to COVID-19 with WorkCompWire.
READ MORE
These provisions expire May 8, 2020, but may be regularly renewed as necessary.
READ MORE
With mass gatherings discouraged or temporarily outlawed, many conferences have been canceled or converted to digital formats.
READ MORE
The FDA’s action surrounding anti-malaria drugs theorized to reduce COVID-19 symptoms.
READ MORE
March 30, 2020
The WCIRB is partnering with workers’ comp organizations across the country
READ MORE
In response to the COVID-19 pandemic, the state issued a delay in adherence.
READ MORE
March 27, 2020
Will disruptions in manufacturing result in drug shortages?
READ MORE
March 20, 2020
Our response to this pandemic, including business continuity measures.
READ MORE
March 19, 2020
FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
READ MORE
March 18, 2020
COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
READ MORE
March 12, 2020
Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.
READ MORE
June 25, 2020
Employee Stress and Mental Health When Returning to Work

Managing employee anxiety after isolation.

Read More
June 25, 2020
Hydroxychloroquine and Remdesivir Updates

The anti-malaria drug is no longer deemed effective.

Read More
June 3, 2020
Remdesivir a Potential Treatment for COVID-19?

Positive trials bode well for this antiviral.

Read More
May 26, 2020
FDA Nixes Certain COVID-19 Antibody Tests

This announcement impacts 31 antibody tests.

Read More
May 13, 2020
Saliva Test with At-Home Collection Authorized

Saliva samples collected at-home must be sent to the designated lab.

Read More
May 12, 2020
By the Numbers:
COVID-19 Edition

A collection of facts and figures surrounding the COVID-19 pandemic

Read More
May 8, 2020
ACOEM and ODG Issue Clinical Guidelines for COVID-19

Update: ACOEM Updates Previous Guidance

Read More
April 30, 2020
Could Convalescent Plasma Treat COVID-19?

The FDA and JAMA think blood from those who recovered from COVID-19 could benefit those still ill.

Read More
April 21, 2020
Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.

Read More
April 21, 2020
FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.

Read More
April 14, 2020
FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.

Read More
April 7, 2020
The Use of Chloroquine and Hydroxychloroquine

The FDA’s action surrounding anti-malaria drugs theorized to reduce COVID-19 symptoms.

Read More
March 27, 2020
FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?

Read More
March 19, 2020
NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.

Read More
March 18, 2020
COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.

Read More
June 29, 2020
NCCI Issues Q2 Economics Briefing

An exploration of job loss due to the COVID-19 pandemic.

Read More
June 21, 2020
WCIRB Examines COVID-19’s Impact on California Comp

WCIRB analyzes historic data on economic cycles.

Read More
June 15, 2020
Florida Publishes 2020 COVID-19 Report

A report on claim data up to May 31st.

Read More
May 31, 2020
California Evaluates Potential Cost Impact of COVID-19 Presumptions

WCIRB Releases Updated May Data

Read More
May 28, 2020
IQVIA Report Explores Shifts in Healthcare During COVID-19 Era

How COVID-19 is impacting healthcare trends.

Read More
April 20, 2020
California State Fund Establishes Two New Funds for COVID-19

$25 million each for essential worker and essential business support funds.

Read More
April 10, 2020
An Update from Our CEO Daryl Corr

A message from Healthesystems leadership.

Read More
April 8, 2020
Conference Cancellations Across the Country

With mass gatherings discouraged or temporarily outlawed, many conferences have been canceled or converted to digital formats.

Read More
March 30, 2020
California Works to Track COVID-19 Claims

The WCIRB is partnering with workers’ comp organizations across the country

Read More
March 20, 2020
Healthesystems Response to COVID-19

Our response to this pandemic, including business continuity measures.

Read More
March 12, 2020
WCIO Updates Injury Description Tables

Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.

Read More
June 25, 2020
Washington Issues Guidelines on COVID-19 Masks for Workers

Certain occupations require different levels of protection.

Read More
June 24, 2020
States Limit COVID-19 Liability

Could Arkansas and Louisiana start a trend?

Read More
June 17, 2020
States Move to Make COVID-19 Compensable

Arkansas and Illinois join in.

Read More
May 26, 2020
CWCI Explores Integration of COVID-19 Claims

COVID-19 claim data was gathered in a survey to understand impacts to comp.

Read More
May 11, 2020
COVID-19 Telehealth Updates

More states relax telehealth rules. New update: Utah & Illinois Join, Connecticut Provides Clarity

Read More
May 8, 2020
Texas Reminds Providers Certain Exams Must Be Done in Person

Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.

Read More
April 27, 2020
NCCI Publishes COVID-19 Resource Center

Lists of compiled information on telehealth, public notices, and more.

Read More
April 20, 2020
NCCI Explores Economic Impacts of COVID-19 on Workers’ Comp

Information on layoffs, shutdowns, access to care, and more.

Read More
April 13, 2020
New York Postpones Formulary Deadlines

Providers receive more time in light of system disruptions due to COVID-19

Read More
April 13, 2020
Louisiana Issues Emergency Prescription Rules

Emergency rules expiring April 13th expanded indefinitely.

Read More
April 9, 2020
Sandy Shtab: Regulatory Acceleration in Response to COVID-19

Healthesystems’ AVP of Advocacy & Compliance discusses the massive state and federal responses to COVID-19 with WorkCompWire.

Read More
April 9, 2020
Kentucky Renews Order Expanding Pharmacist Powers

These provisions expire May 8, 2020, but may be regularly renewed as necessary.

Read More
March 30, 2020
Montana Delays Drug Formulary for Legacy Claims

In response to the COVID-19 pandemic, the state issued a delay in adherence.

Read More